Spatial Multiomic Analysis for Single-Cell Tissue Profiling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current genomic and molecular technologies lack the capability to provide a high-resolution view of DNA, RNA, and proteins in individual cells and their spatial arrangement, hindering understanding of cell co-localization and disease progression, such as cancer, and limiting their integration into routine clinical practice.

Innovation Solution

A device and methods for multiomic analysis that enable in situ single-cell and tissue analysis, providing RNA transcription and protein expression analysis, capable of measuring sequence-specific information directly in cells and tissues, integrating cell morphology with marker-based assessment for improved disease detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If current sequencing technologies are used, then genomic analysis can be performed, but high-resolution view of DNA, RNA, and proteins in individual cells with spatial arrangement cannot be obtained

Engineering Contradiction:
Improveresolution of molecular viewVSAvoidcomplexity of multiomic analysis system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent combines multiple omics layers (genomics, transcriptomics, proteomics, epigenomics) into a single integrated platform that performs multiomic analysis simultaneously. This merging of previously separate analyses enables high-resolution molecular viewing while managing complexity through unified processing architecture.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The sequencing platform is designed with universal capabilities to handle multiple types of molecular analyses (DNA sequencing, RNA sequencing, protein analysis, epigenetic modifications) through a single device system. This multi-functionality achieves high-resolution molecular views across different biomolecule types without requiring separate specialized instruments for each analysis.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If single-cell technologies are used, then cellular heterogeneity can be profiled, but spatial arrangement and cell co-localization information are lost

Engineering Contradiction:
Improveprecision of single-cell profilingVSAvoidloss of spatial arrangement data
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The patent adds spatial dimensionality to single-cell analysis by preserving and analyzing the physical location and spatial arrangement of cells and molecular structures. This dimensional extension enables simultaneous profiling of cellular heterogeneity and spatial relationships, preventing loss of location information while maintaining single-cell resolution.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The analysis platform implements nested processing where molecular profiling at single-cell resolution is combined with tissue-level spatial context. Individual cell data is nested within the broader tissue architecture, allowing concurrent analysis of cellular heterogeneity and spatial arrangement without information loss.

Inventive Principle:
Principle #7Nested doll (Nesting)

3Adaptability or versatility

If multiomics approach is implemented, then comprehensive biological analysis is achieved, but integration into routine clinical practice is limited

Engineering Contradiction:
Improvecomprehensive biological analysis capabilityVSAvoidease of clinical integration
Core Design Contradiction:
Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

The multiomic analysis system is segmented into modular components that can be independently optimized and deployed. This segmentation enables comprehensive biological analysis while facilitating gradual integration into clinical practice through phased implementation and selective application of different analytical modules based on clinical needs.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The platform enables flexible adjustment of analysis parameters and omics layers based on specific clinical applications. This adaptability allows comprehensive biological analysis when needed while simplifying the approach for routine clinical practice by adjusting the scope and depth of multiomic analysis to match clinical requirements.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20260009069A1Multiomic analysis device and methods of use thereof
Publication Date: 2026.01.08 SINGULAR GENOMICS SYSTEMS INC
  • US20260009069A1 patent drawing
  • US20260009069A1 patent drawing
  • US20260009069A1 patent drawing

AI summary

Disclosed herein, inter alia, are devices, compositions, kits, and methods for interrogating biological samples.